RUSSELL FRANK CO/ - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$1,923,000
-76.2%
120,278
-56.3%
0.00%
-78.6%
Q4 2015$8,093,000
+62.6%
275,455
+57.5%
0.01%
+55.6%
Q3 2015$4,977,000
+3.2%
174,892
+30.3%
0.01%
+12.5%
Q2 2015$4,823,000
+24.7%
134,266
+101.8%
0.01%
+14.3%
Q1 2015$3,867,000
+108.9%
66,524
+19.2%
0.01%
+133.3%
Q3 2013$1,851,00055,8280.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders